About UsMyomo TherapyClinical StudiesTechnologyResources

OVERVIEW
MEDICAL PROFESSIONALS
Product
Therapy Guidelines
>What the
Research Shows
>What a Patient
Session Entails
Who is a Candidate?
PATIENTS & FAMILIES
INDICATIONS & CONTRAINDICATIONS
 

Therapy Guidelines

The Myomo e100 NeuroRobotic System is a non-invasive upper extremity robotic tool that is worn and controlled by a patient's electrical muscle activity (EMG) signal. The device was created to assist therapists in achieving optimal, goal-oriented outcomes with stroke patients.

Through its portability and ability to seamlessly interface into a variety of clinical settings, the device can be used to facilitate a range of therapeutic strategies. With the turn of a dial, a therapist can quickly customize the device for each individual patient in approximately minutes, so the focus of training sessions are on the therapy, not the device set up.

Note: Federal (USA) law restricts this device to sale by or on the order of a physician or physical therapist.

Note: The Myomo e100 NeuroRobotic System is intended for clinical use by patients with their treating medical professional. The device has not been shown to be safe or effective as a functional aid for use in the home.

 

 

 

"We are excited about the Myomo technology since its unique combination of EMG control and portable robotics may improve functional upper extremity motor recovery and function after a neurologic injury. By providing a tool for therapists to actively engage patients in high dosage, repetitive, meaningful tasks, the Myomo device holds great potential in helping neurologically impaired patients achieve better function."

—Dan Parkinson, PT
Director of Clinical Services, Braintree Rehabilitation Hospital, Braintree, MA, and site investigator of the Myomo Functional Task Study

 

 

 
© 2008 Myomo, Inc. All rights Reserved.
MYOMO, e100 NeuroRobotic System, Neurobotics, NeuroRobotics and
MyoRobotics are trademarks in registration of Myomo, Inc.
The Myomo, Inc. e100 NeuroRobotic System is patent pending.

Legal Terms | Privacy Policy | Antispamming Policy

Site by 451 Marketing